Aarti Drugs Screener - Aarti Drugs Ltd Screener by BlinkX

Home

Stocks Screener

Aarti Drugs Ltd Screener

Market Cap

₹ 4,202.35 Cr.

Stocks P/E

27.57

PB Ratio

3.28 %

Current Price

₹ 447.75

Book Value

₹ 139.02

ROE

11.92 %

High/Low

₹ 635/419.55

Dividend Yield

0.22 %

Face Value

₹ 1

Small Cap

With a marketcap of ₹ 4,202.35 Cr Stock is ranked 855

Aarti Drugs Investment Return

Short Term

1 Week

-0.89 %

1 Month

0.22 %

3 Months

-10.30 %

6 Months

-17.37 %

Long Term

1 Year

-8.96 %

3 Years

-12.67 %

5 Years

218.26 %

10 Years

302.57 %

Aarti Drugs Return Calculator

Investment

₹

Investment Period

Expected Return

₹ 0

Invested Amount

Wealth Gained

₹ 0

Expected Return

Aarti Drugs Revenue and Profit and Growth

Strength

The company's Book Value Per Share (BVPS) is improving consistently for last 2 years
The company's Operating Cash Flow is improving with good durability
The company's net cash flow is improving for last 2 quarters.
The stock price of the company is lurking near its 52 week low

Weakness

The Price of Rs. 459.65 of the company is under its 50 Day SMA of Rs 503.19, 100 Day SMA of Rs 519.12, 200 Day SMA of Rs 507.32 and 20 Day EMA of Rs 479.31
RSI of the company is 29.52
RSI of the company is 29.6

Aarti Drugs Screener FAQs

The Aarti Drugs screener can be used to check different types of data, such as market capitalization, stock P/E, PB ratio, current price, book value, ROE, 52W high/low, dividend yield, and face value. It also shows short-term and long-term data of the Aarti Drugs.

You can use the Aarti Drugs stock screener to analyze stocks based on specific criteria, helping you choose stocks for investments based on real-time data.

Yes, you can use the Aarti Drugs Stock Screener for both short-term and long-term. Using the short term, you can check data for periods ranging from 1 week to 6 months. On the other hand, if you are looking to invest long-term, you can check data for periods ranging from 1 year to 10 years.

Join the

Future of Trading

with BlinkX

#ItsATraderThing